Nordic Nanovector is committed to developing and delivering innovative therapies to patients to address major unmet medical needs. The Company aspires to become a leader in the development of CD37-targeted therapies for hematological cancers and immune diseases.

Biotechnology

Nordic Nanovector

Ludvik Sandnes

Stein Rune Kjelby

margrethe Sørgaard

Lars Nieba

Jostein Dahle

The Leadership Team at Nordic Nanovector drives the strategic direction and vision for the company, focusing on the development and delivery of innovative CD37-targeted therapies. Comprising key executives with extensive scientific and technical expertise, the team fosters collaboration, oversees research initiatives, and ensures alignment with the company's mission to address unmet medical needs in hematological cancers and immune diseases.

��

Leadership Team

About

Team members

Other teams at Nordic Nanovector

Scientific Advisory Team

��������

Leadership Team

About

Team members

Other teams at Nordic Nanovector

Scientific Advisory Team

��